ReviewJournal of clinical medicine2023

Efficacy of PARP Inhibitor, Platinum, and Immunotherapy in BRCA-Mutated HER2-Negative Breast Cancer Patients: A Systematic Review and Network Meta-Analysis.

Wanyi Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.